You’ll find everything you need to prepare for this groundbreaking event with America’s #1 stock catalyst expert Marc Lichtenfeld right here.
So please bookmark this page. And check back often for the latest information and announcements leading up to the big event.
Marc can’t wait to share with you all of his findings on a company he calls Nvidia’s favorite biotech.
It’s a tiny firm trading for about $10 that just got a MAJOR investment from the AI powerhouse.
According to Marc, Nvidia made this strategic move just ahead of a major announcement that could send shockwaves through the market. And land Nvidia a small fortune.
It’s all set to kick off in just a few days… when this tiny firm will make that huge announcement.
Marc says it’s poised to ignite a revolution in AI biotech... and could make early investors a fortune.
Here are all the details on the ONE EVENT that could make the biggest impact of your financial future...
| WHO | World-class biotech investment analyst and America’s #1 stock catalyst expert Marc Lichtenfeld |
| WHAT | The PREMIER AI event of the year where you’ll discover... Why Nvidia Is Going All in on This $10 TechBio Stock. |
| WHEN | On Thursday, June 27, 2024 at 2 P.M. ET. |
You won’t want to miss a second of this...
During this free, no-strings-attached event, you’ll discover:
- The shocking details of how this firm that’s less than 1/10th the size of Nvidia was the one out of 6,600 biotechs that caught the eye of the AI giant. And how it led to a surprising partnership that could spark the next trillion–dollar company.
- Why an imminent announcement from this under–the–radar company could trigger a frenzy of buying and potential explosive gains – even greater than FDA approval.
- Three simple reasons this company’s small market cap could “automatically” triple.
- The unique way to play this developing situation that Marc Lichtenfeld believes could lead to "the greatest stock success story of our lifetime." It will position you for the biggest possible short–term gains and let you ride this company’s success all the way to the top.
- The lucrative catalyst events Marc has capitalized on before... Like the 907% gain in under a year that made one follower a rare $1.3 million. And you’ll hear details on how he spots these powerful catalysts.
We’ll email some articles and updates prior to the event so be sure to watch your inbox. And we’ll post all of the material right here so you don’t risk missing any of it.
Marc can’t wait to share all of the details with you.
So mark your calendar NOW for Thursday, June 27, 2024 at 2 pm ET.
Featured Expert Marc Lichtenfeld
_UberShoot_2018-circle.png)
Marc Lichtenfeld
Stock Catalyst Expert,
Chief Income Strategist,
The Oxford Club
Best-selling financial author, Marc Lichtenfeld, is America’s #1 stock catalyst expert.
He’s spent decades studying and trading the biotech sector, having met privately with the doctor known as “the father of stem cell research”… a medical CEO ranked among Fortune Small Business 100’s richest executives … world famous scientists… managers of multi-million dollar biotech hedge funds... and more.
Marc has been a regular attendee at the invitation-only JP Morgan Healthcare Conference.
And since 2007, he’s helped countless Oxford Club members take their wealth to the next level...
“You did a crazy–awesome job. Marc, you are THE MAN! But your math is lame (kidding!). You said a possible 173% gain? But I’m calculating a 493% gain in 3 months, right? I’m not sure. I’ve never had to calculate such crazy gains... Holy cow!”
Allen Kepler, Arizona
“Great win! I made 113% overnight!”
Shawn Foley, Texas
“I put $10,800 into the trade in August and made a profit of $24,000 by March. I’m taking that money and going to Hawaii in the winter!”
Terrence Beatty, Delaware
“I got crucified in 2009, losing 85% of my portfolio. Then, years later, I started building up a small base following your recommendations. I’m happy to report that my portfolio – though small – has increased 300% in the last 12 months. I’m excited every morning to look at my positions and wait for your next recommendation.”
Bart Bourke, Australia
“I'm a paralyzed veteran, 53 years old. I'm not able to work in a traditional job anymore. My wife and I have 6 kids and 6 grandkids, and we're able to spend more time with them now because we are financially independent.”
Bill Stanton, Montana
